Yidu Tech Inc. has announced its annual results for the fiscal year ended 31 March 2025. The company reported total revenue of RMB715.0 million, marking an 11.4% decrease from the previous year. This decline was attributed to changes in the external market environment and product portfolios. Despite the revenue drop, Yidu Tech managed to narrow its loss for the year to RMB135.2 million, a 38.9% reduction compared to the prior year. The company's Life Sciences Solutions segment experienced a significant revenue decrease of 23.7%, totaling RMB247.1 million. Meanwhile, the Big Data Platform and Solutions segment saw a 10.3% increase in revenue, amounting to RMB345.9 million. The Health Management Platform and Solutions segment reported a 28.0% decline in revenue, reaching RMB122.0 million. Yidu Tech highlighted improvements in internal operational efficiency and enhanced synergies among business segments as contributing factors to the reduced loss. The company also reported a decrease in net cash outflow from operating activities by 23.8% year-on-year. As of 31 March 2025, the company maintained sufficient cash reserves, with cash and cash equivalents, term deposits, and other bank balances totaling RMB3,309.1 million.
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。